Zynerba Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:ZYNE)

Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) saw some unusual options trading activity on Tuesday. Traders bought 2,036 put options on the company. This is an increase of approximately 1,655% compared to the typical volume of 116 put options.

Institutional investors and hedge funds have recently bought and sold shares of the stock. SG Americas Securities LLC acquired a new stake in Zynerba Pharmaceuticals during the 2nd quarter worth approximately $210,000. Claraphi Advisory Network LLC increased its position in Zynerba Pharmaceuticals by 46.2% during the 2nd quarter. Claraphi Advisory Network LLC now owns 17,503 shares of the company’s stock worth $237,000 after purchasing an additional 5,532 shares in the last quarter. Commonwealth Equity Services LLC acquired a new stake in Zynerba Pharmaceuticals during the 2nd quarter worth approximately $182,000. NEXT Financial Group Inc increased its position in Zynerba Pharmaceuticals by 1,190.0% during

... read more at: https://technewsobserver.com/news/2019/09/05/zynerba-pharmaceuticals-sees-unusually-high-options-volume-nasdaqzyne.html

by

Leave a Reply